These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23709058)

  • 1. Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III.
    Fan J; Liu Y; Xie X; Zhang B; Yuan Z
    Virol Sin; 2013 Jun; 28(3):152-60. PubMed ID: 23709058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.
    Li SH; Li XF; Zhao H; Jiang T; Deng YQ; Yu XD; Zhu QY; Qin ED; Qin CF
    Immunol Lett; 2011 Aug; 138(2):156-60. PubMed ID: 21515306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to Porcine Stable Kidney cells.
    Verma SK; Gupta N; Pattnaik P; Babu JP; Rao PV; Kumar S
    Protein Pept Lett; 2009; 16(11):1334-41. PubMed ID: 20001924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III.
    Zu X; Liu Y; Wang S; Jin R; Zhou Z; Liu H; Gong R; Xiao G; Wang W
    Antiviral Res; 2014 Apr; 104():7-14. PubMed ID: 24468276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Japanese encephalitis virus entry into the cells by the envelope glycoprotein domain III (EDIII) and the loop3 peptide derived from EDIII.
    Li C; Zhang LY; Sun MX; Li PP; Huang L; Wei JC; Yao YL; Isahg H; Chen PY; Mao X
    Antiviral Res; 2012 May; 94(2):179-83. PubMed ID: 22465300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRP78 Is an Important Host Factor for Japanese Encephalitis Virus Entry and Replication in Mammalian Cells.
    Nain M; Mukherjee S; Karmakar SP; Paton AW; Paton JC; Abdin MZ; Basu A; Kalia M; Vrati S
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective inhibition of Japanese encephalitis virus replication by shRNAs targeting various viral genes in vitro and in vivo.
    Shen T; Liu K; Miao D; Cao R; Chen P
    Virology; 2014 Apr; 454-455():48-59. PubMed ID: 24725931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
    Chu JH; Chiang CC; Ng ML
    J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism through Which Retrocyclin Targets Flavivirus Multiplication.
    Jia X; Guo J; Yuan W; Sun L; Liu Y; Zhou M; Xiao G; Lu W; Garzino-Demo A; Wang W
    J Virol; 2021 Jul; 95(15):e0056021. PubMed ID: 33980602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.
    Martina BE; Koraka P; van den Doel P; van Amerongen G; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2008 Jan; 26(2):153-7. PubMed ID: 18069096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo.
    Ishag HZ; Li C; Huang L; Sun MX; Wang F; Ni B; Malik T; Chen PY; Mao X
    Arch Virol; 2013 Feb; 158(2):349-58. PubMed ID: 23053519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenicity and antigenicity of Japanese encephalitis virus envelope protein domain III].
    Huang Y; Liu S; Yang P; Du Y; Sun Z; Yu W
    Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1532-7. PubMed ID: 20112698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.
    Chu JJH; Rajamanonmani R; Li J; Bhuvanakantham R; Lescar J; Ng ML
    J Gen Virol; 2005 Feb; 86(Pt 2):405-412. PubMed ID: 15659760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo.
    Sebastian L; Desai A; Shampur MN; Perumal Y; Sriram D; Vasanthapuram R
    Virol J; 2008 May; 5():64. PubMed ID: 18498627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mosGCTL-7, a C-Type Lectin Protein, Mediates Japanese Encephalitis Virus Infection in Mosquitoes.
    Liu K; Qian Y; Jung YS; Zhou B; Cao R; Shen T; Shao D; Wei J; Ma Z; Chen P; Zhu H; Qiu Y
    J Virol; 2017 May; 91(10):. PubMed ID: 28250133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus.
    Lin CW; Liu KT; Huang HD; Chen WJ
    Biotechnol Lett; 2008 Feb; 30(2):205-14. PubMed ID: 17876533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage.
    Imran M; Saleemi MK; Chen Z; Wang X; Zhou D; Li Y; Zhao Z; Zheng B; Li Q; Cao S; Ye J
    Viruses; 2019 Oct; 11(11):. PubMed ID: 31683742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neuron-specific antiviral mechanism prevents lethal flaviviral infection of mosquitoes.
    Xiao X; Zhang R; Pang X; Liang G; Wang P; Cheng G
    PLoS Pathog; 2015 Apr; 11(4):e1004848. PubMed ID: 25915054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus.
    Fernandez E; Kose N; Edeling MA; Adhikari J; Sapparapu G; Lazarte SM; Nelson CA; Govero J; Gross ML; Fremont DH; Crowe JE; Diamond MS
    mBio; 2018 Feb; 9(1):. PubMed ID: 29487230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.
    Verma SK; Kumar S; Gupta N; Vedi S; Bhattacharya SM; Lakshmana Rao PV
    Vaccine; 2009 Nov; 27(49):6905-9. PubMed ID: 19761840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.